Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway

Fig. 1

CYT387 inhibits proliferation in glioblastoma cells. A Half maximal inhibitory concentration (IC50) of CYT387 was measured by CCK-8 in U87-MG and LN229 cells. B Glioblastoma cells treated with CYT387 dramatically decreased the capacity of proliferation using CCK-8 assay. C Colony formation assay showed decreased ability of forming colonies after treatment with CYT387. All experiments were repeated at least three times. (*p < 0.05; **p < 0.01; ***p < 0.001)

Back to article page